Related Experiment Video
Updated: May 11, 2026
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Protective effect of sevoflurane on hepatic ischaemia/reperfusion injury in the rat: A dose-response study
Shao-Peng Zhou1, Ping Jiang, Lu Liu
1Department of Anesthesiology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China. zsp005@163.com
Background:
Ischaemia/reperfusion injury is a common problem in hepatic surgery. An appreciation of the role of sevoflurane dose in preconditioning and subsequent hepatoprotection against ischaemia/reperfusion injury would be useful.
Objective:
The aim of current study was to investigate the protective effect of sevoflurane preconditioning at different doses on hepatic ischaemia/reperfusion injury in rats.
Design:
Randomised, controlled, laboratory study.
Setting:
The Department of Anaesthesiology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Participants:
Fifty male Sprague-Dawley rats weighing 200 to 250 g, randomly assigned to five groups.
Interventions:
Control group (sham surgery, no ischaemia/reperfusion), I/R group (ischaemia/reperfusion but no sevoflurane pretreatment), S1 [1 minimum alveolar concentration (MAC) = 2.4%], S2 (1.5 MAC = 3.6%) and S3 (2 MAC = 4.8%) groups with sevoflurane pretreatment, respectively, followed by 60 min ischaemia and 120 min reperfusion.
Main Outcome Measures:
At the end of reperfusion, serum levels of alanine aminotransferase and aspartate aminotransferase as well as superoxide dismutase activity, myeloperoxidase and malondialdehyde content in the liver were determined. Histological examination of the liver was also performed.
Results:
Serum levels of aspartate aminotransferase and alanine aminotransferase in the sevoflurane groups were significantly reduced compared to the elevated levels seen in the I/R group (P < 0.05). In the liver, the I/R-induced increase in myeloperoxidase activity and malondialdehyde level were significantly reduced by all sevoflurane concentrations (P < 0.05). The decrease in superoxide dismutase activity induced by I/R was prevented by all sevoflurane pretreatments (P < 0.05). No significant differences between the S1, S2 and S3 groups were seen in any of the above variables.
Conclusion:
Sevoflurane pretreatment exerts a protective effect on hepatic ischaemia/reperfusion injury but there is no significant dose-response relationship in the concentration range used. It is possible that a dose-response relationship might exist at lower concentrations.
